Delaware
|
1-31719
|
13-4204626
|
||
(State of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01. | Financial Statements and Exhibits. |
(d) | Exhibits: |
No. | Description |
99.1 |
Press release of Molina Healthcare, Inc. issued February 7, 2013, as to financial results for the fourth quarter and year ended December 31, 2012.
|
MOLINA HEALTHCARE, INC.
|
||||
Date: February 7, 2013
|
By: /s/ Jeff D. Barlow
|
|||
Jeff D. Barlow
Sr. Vice President – General Counsel, and Secretary
|
Exhibit
No.
|
Description |
99.1 | Press release of Molina Healthcare, Inc. issued February 7, 2013, as to financial results for the fourth quarter and year ended December 31, 2012. |
●
|
Quarterly earnings per diluted share of $0.54
|
●
|
Full year earnings per diluted share of $0.21
|
●
|
Annual revenue of $6 billion, up 26% over 2011
|
●
|
Aggregate membership up 6% over 2011
|
●
|
Earnings per diluted share guidance of $1.55 for fiscal year 2013
|
●
|
An increase to premium rates of approximately 1%, or approximately $200,000 per month, at the Florida health plan effective September 1, 2012;
|
●
|
An increase to premium rates of approximately 2%, or approximately $900,000 per month, at the Michigan health plan effective October 1, 2012;
|
●
|
An increase to premium rates of approximately 4%, or approximately $4.5 million per month, at the Texas health plan effective September 1, 2012; and
|
●
|
An increase to premium rates for the aged, blind or disabled, or ABD, population of approximately 2% at the California health plan retroactive to July 1, 2011. This increase translated to a blended rate increase of approximately 1% for the California health plan’s premium revenue overall. Due to the retroactive nature of this increase, the California health plan recorded approximately $12 million of incremental revenue (net of related costs) in the fourth quarter of 2012. Approximately $4 million of the retroactive revenue related to 2011 and $2 million to each of the four quarters of 2012. Revenue beginning October 1, 2012, increased about $2 million per quarter.
|
●
|
A blended rate increase of approximately 4%, or $4.5 million per month, effective September 1, 2012;
|
●
|
The results of medical cost containment initiatives implemented beginning in the second quarter of 2012; and
|
●
|
A reduction of approximately $30 million to the estimated amount of medical costs incurred prior to the fourth quarter of 2012. The change in that estimate was recorded in the fourth quarter of 2012.
|
Three Months Ended
December 31,
|
Year Ended
December 31,
|
|||||||||||||||
2012
|
2011
|
2012
|
2011
|
|||||||||||||
(Amounts in thousands)
|
||||||||||||||||
Net income (loss)
|
$ | 25,643 | $ | (32,960 | ) | $ | 9,790 | $ | 20,818 | |||||||
Add back:
|
||||||||||||||||
Depreciation and amortization reported in the consolidated statements of cash flows
|
20,475 | 21,969 | 78,764 | 74,383 | ||||||||||||
Interest expense
|
4,348 | 3,853 | 16,769 | 15,519 | ||||||||||||
Provision for income taxes
|
24,503 | 13,004 | 9,275 | 43,836 | ||||||||||||
EBITDA
|
$ | 74,969 | $ | 5,866 | $ | 114,598 | $ | 154,556 |
(1)
|
GAAP stands for U.S. generally accepted accounting principles.
|
(2)
|
EBITDA is not prepared in conformity with GAAP because it excludes depreciation and amortization, as well as interest expense, and the provision for income taxes. This non-GAAP financial measure should not be considered as an alternative to the GAAP measures of net income, operating income, operating margin, or cash provided by operating activities, nor should EBITDA be considered in isolation from these GAAP measures of operating performance. Management uses EBITDA as a supplemental metric in evaluating the Company’s financial performance, in evaluating financing and business development decisions, and in forecasting and analyzing future periods. For these reasons, management believes that EBITDA is a useful supplemental measure to investors in evaluating the Company’s performance and the performance of other companies in the Company’s industry.
|
●
|
uncertainties associated with the implementation of the Affordable Care Act, including the impact of the health insurance industry excise tax, the expansion of Medicaid eligibility in the states that participate to previously uninsured populations unfamiliar with managed care, the implementation of state insurance exchanges currently expected to become operational by October 1, 2013, the effect of various implementing regulations, and uncertainties regarding the impact of other federal or state health care and insurance reform measures, including the duals demonstration programs in California, Ohio, Michigan, and Texas;
|
●
|
the success of our medical cost containment initiatives in Texas, and other risks associated with the expansion of our Texas health plan’s service areas in 2012;
|
●
|
significant budget pressures on state governments and their potential inability to maintain current rates, to implement expected rate increases, or to maintain existing benefit packages or membership eligibility thresholds or criteria;
|
●
|
management of our medical costs, including seasonal flu patterns and rates of utilization that are consistent with our expectations and our incurred but not reported accruals;
|
●
|
the success of our efforts to retain existing government contracts and to obtain new government contracts in connection with state requests for proposals (RFPs) in both existing and new states, and our ability to increase our revenues consistent with our expectations;
|
●
|
accurate estimation of incurred but not reported medical costs across our health plans;
|
●
|
risks associated with the continued growth in new Medicaid and Medicare enrollees, and the development of actuarially sound rates with respect to such new enrollees, including duals;
|
●
|
retroactive adjustments to premium revenue or accounting estimates which require adjustment based upon subsequent developments, including Medicaid pharmaceutical rebates;
|
●
|
continuation and renewal of the government contracts of both our health plans and Molina Medicaid Solutions and the terms under which such contracts are renewed;
|
●
|
government audits and reviews, and any enrollment freeze or monitoring program that may result therefrom;
|
●
|
changes with respect to our provider contracts and the loss of providers;
|
●
|
the establishment of a federal or state medical cost expenditure floor as a percentage of the premiums we receive, and the interpretation and implementation of medical cost expenditure floors, administrative cost and profit ceilings, and profit sharing arrangements;
|
●
|
interpretation and implementation of at-risk premium rules regarding the achievement of certain quality measures;
|
●
|
approval by state regulators of dividends and distributions by our health plan subsidiaries;
|
●
|
changes in funding under our contracts as a result of regulatory changes, programmatic adjustments, or other reforms;
|
●
|
high dollar claims related to catastrophic illness;
|
●
|
the favorable resolution of litigation, arbitration, or administrative proceedings, including our pending litigation against the state of California related to rates paid to our California plan in earlier years that were not actuarially sound;
|
●
|
restrictions and covenants in our credit facility;
|
●
|
the relatively small number of states in which we operate health plans;
|
●
|
the availability of adequate financing to fund and capitalize our expansion and growth activities and to meet our liquidity needs, including the interest expense and other costs associated with such financing;
|
●
|
a state’s failure to renew its federal Medicaid waiver;
|
●
|
inadvertent unauthorized disclosure of protected health information;
|
●
|
changes generally affecting the managed care or Medicaid management information systems industries;
|
●
|
increases in government surcharges, taxes, and assessments;
|
●
|
changes in general economic conditions, including unemployment rates; and
|
●
|
increasing consolidation in the Medicaid industry;
|
Three Months Ended
December 31,
|
Year Ended
December 31,
|
|||||||||||||||
2012
|
2011
|
2012
|
2011
|
|||||||||||||
(Amounts in thousands, except net income (loss) per share)
|
||||||||||||||||
Revenue:
|
||||||||||||||||
Premium revenue
|
$ | 1,480,014 | $ | 1,211,013 | $ | 5,667,500 | $ | 4,448,818 | ||||||||
Premium tax
|
38,038 | 43,956 | 158,991 | 154,589 | ||||||||||||
Service revenue
|
55,359 | 49,157 | 187,710 | 160,447 | ||||||||||||
Investment income
|
1,192 | 1,735 | 5,188 | 5,539 | ||||||||||||
Rental income
|
3,966 | 547 | 9,374 | 547 | ||||||||||||
Total revenue
|
1,578,569 | 1,306,408 | 6,028,763 | 4,769,940 | ||||||||||||
Expenses:
|
||||||||||||||||
Medical care costs
|
1,273,624 | 1,037,945 | 5,096,760 | 3,859,994 | ||||||||||||
Cost of service revenue
|
43,097 | 38,967 | 141,208 | 143,987 | ||||||||||||
General and administrative expenses
|
153,419 | 124,965 | 532,627 | 415,932 | ||||||||||||
Premium tax expenses
|
38,038 | 43,956 | 158,991 | 154,589 | ||||||||||||
Depreciation and amortization
|
16,258 | 12,103 | 63,704 | 50,690 | ||||||||||||
Total expenses
|
1,524,436 | 1,257,936 | 5,993,290 | 4,625,192 | ||||||||||||
Impairment of goodwill and intangible assets
|
– | (64,575 | ) | – | (64,575 | ) | ||||||||||
Operating income (loss)
|
54,133 | (16,103 | ) | 35,473 | 80,173 | |||||||||||
Other expenses (income):
|
||||||||||||||||
Interest expense
|
4,348 | 3,853 | 16,769 | 15,519 | ||||||||||||
Other income
|
(361 | ) | – | (361 | ) | – | ||||||||||
Total other expenses (income)
|
3,987 | 3,853 | 16,408 | 15,519 | ||||||||||||
Income (loss) before income taxes
|
50,146 | (19,956 | ) | 19,065 | 64,654 | |||||||||||
Provision for income taxes
|
24,503 | 13,004 | 9,275 | 43,836 | ||||||||||||
Net income (loss)
|
$ | 25,643 | $ | (32,960 | ) | $ | 9,790 | $ | 20,818 | |||||||
Net income (loss) per share:
|
||||||||||||||||
Basic
|
$ | 0.55 | $ | (0.72 | ) | $ | 0.21 | $ | 0.45 | |||||||
Diluted
|
$ | 0.54 | $ | (0.72 | ) | $ | 0.21 | $ | 0.45 | |||||||
Weighted average shares outstanding:
|
||||||||||||||||
Basic
|
46,617 | 45,702 | 46,380 | 45,756 | ||||||||||||
Diluted
|
47,143 | 45,702 | 46,999 | 46,425 | ||||||||||||
Operating Statistics:
|
||||||||||||||||
Ratio of medical care costs paid directly to providers to premium revenue
|
83.9 | % | 83.6 | % | 87.6 | % | 84.5 | % | ||||||||
Ratio of medical care costs not paid directly to providers to premium revenue
|
2.2 | % | 2.1 | % | 2.3 | % | 2.3 | % | ||||||||
Medical care ratio (1)
|
86.1 | % | 85.7 | % | 89.9 | % | 86.8 | % | ||||||||
Service revenue ratio (2)
|
77.9 | % | 79.3 | % | 75.2 | % | 89.7 | % | ||||||||
General and administrative expense ratio (3)
|
9.7 | % | 9.6 | % | 8.8 | % | 8.7 | % | ||||||||
Premium tax ratio (1)
|
2.6 | % | 3.6 | % | 2.8 | % | 3.5 | % | ||||||||
Effective tax rate
|
48.9 | % | (65.2 | )% | 48.6 | % | 67.8 | % |
(1)
|
Medical care ratio represents medical care costs as a percentage of premium revenue, net of premium taxes; premium tax ratio represents premium taxes as a percentage of premium revenue, net of premium taxes.
|
(2)
|
Service revenue ratio represents cost of service revenue as a percentage of service revenue.
|
(3)
|
Computed as a percentage of total revenue.
|
December 31,
|
||||||||
2012
|
2011
|
|||||||
(Amounts in thousands,
except per-share data)
|
||||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$ | 795,770 | $ | 493,827 | ||||
Investments
|
342,845 | 336,916 | ||||||
Receivables
|
149,682 | 167,898 | ||||||
Income tax refundable
|
– | 11,679 | ||||||
Deferred income taxes
|
32,443 | 18,327 | ||||||
Prepaid expenses and other current assets
|
28,386 | 19,435 | ||||||
Total current assets
|
1,349,126 | 1,048,082 | ||||||
Property, equipment, and capitalized software, net
|
221,443 | 190,934 | ||||||
Deferred contract costs
|
58,313 | 54,582 | ||||||
Intangible assets, net
|
77,711 | 101,796 | ||||||
Goodwill and indefinite-lived intangible assets
|
151,088 | 153,954 | ||||||
Auction rate securities
|
13,419 | 16,134 | ||||||
Restricted investments
|
44,101 | 46,164 | ||||||
Receivable for ceded life and annuity contracts
|
– | 23,401 | ||||||
Other assets
|
19,621 | 17,099 | ||||||
$ | 1,934,822 | $ | 1,652,146 | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Medical claims and benefits payable
|
$ | 494,530 | $ | 402,476 | ||||
Accounts payable and accrued liabilities
|
184,034 | 147,214 | ||||||
Deferred revenue
|
141,798 | 50,947 | ||||||
Income taxes payable
|
6,520 | – | ||||||
Current maturities of long-term debt
|
1,155 | 1,197 | ||||||
Total current liabilities
|
828,037 | 601,834 | ||||||
Long-term debt
|
261,784 | 216,929 | ||||||
Deferred income taxes
|
37,900 | 33,127 | ||||||
Liability for ceded life and annuity contracts
|
– | 23,401 | ||||||
Other long-term liabilities
|
24,787 | 21,782 | ||||||
Total liabilities
|
1,152,508 | 897,073 | ||||||
Stockholders’ equity:
|
||||||||
Common stock, $0.001 par value; 80,000 shares authorized;
outstanding: 46,762 shares at December 31, 2012 and 45,815 shares
at December 31, 2011
|
47 | 46 | ||||||
Preferred stock, $0.001 par value; 20,000 shares authorized, no shares issued and outstanding
|
– | – | ||||||
Additional paid-in capital
|
285,524 | 266,022 | ||||||
Accumulated other comprehensive loss
|
(457 | ) | (1,405 | ) | ||||
Treasury stock, at cost; 111 shares at December 31, 2012
|
(3,000 | ) | – | |||||
Retained earnings
|
500,200 | 490,410 | ||||||
Total stockholders’ equity
|
782,314 | 755,073 | ||||||
$ | 1,934,822 | $ | 1,652,146 |
Three Months Ended December 31,
|
Year Ended
December 31,
|
|||||||||||||||
2012
|
2011
|
2012
|
2011
|
|||||||||||||
(Amounts in thousands)
|
||||||||||||||||
Operating activities:
|
||||||||||||||||
Net income (loss)
|
$ | 25,643 | $ | (32,960 | ) | $ | 9,790 | $ | 20,818 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||||||
Depreciation and amortization
|
20,475 | 21,969 | 78,764 | 74,383 | ||||||||||||
Deferred income taxes
|
(11,053 | ) | 5,767 | (9,887 | ) | 13,836 | ||||||||||
Stock-based compensation
|
4,570 | 4,329 | 20,018 | 17,052 | ||||||||||||
Non-cash interest on convertible senior notes
|
1,528 | 1,417 | 5,942 | 5,512 | ||||||||||||
Impairment of goodwill and intangible assets
|
– | 64,575 | – | 64,575 | ||||||||||||
Change in fair value of interest rate swap
|
37 | – | 1,307 | – | ||||||||||||
Amortization of premium/discount on investments
|
1,580 | 1,942 | 6,746 | 7,242 | ||||||||||||
Amortization of deferred financing costs
|
264 | 367 | 1,089 | 2,818 | ||||||||||||
Gain on sale of subsidiary
|
643 | – | (1,747 | ) | – | |||||||||||
Gain on acquisition
|
– | (1,676 | ) | – | (1,676 | ) | ||||||||||
Loss on disposal of property and equipment
|
2,608 | – | 2,608 | – | ||||||||||||
Tax deficiency from employee stock compensation
|
(367 | ) | (67 | ) | (526 | ) | (714 | ) | ||||||||
Changes in operating assets and liabilities:
|
||||||||||||||||
Receivables
|
7,227 | (5,059 | ) | 18,216 | 352 | |||||||||||
Prepaid expenses and other current assets
|
1,616 | 5,127 | (8,958 | ) | 3,308 | |||||||||||
Medical claims and benefits payable
|
(41,933 | ) | 41,421 | 92,054 | 48,120 | |||||||||||
Accounts payable and accrued liabilities
|
28,888 | 2,532 | 19,858 | 2,778 | ||||||||||||
Deferred revenue
|
(1,503 | ) | (33,554 | ) | 90,851 | (8,154 | ) | |||||||||
Income taxes
|
40,050 | (5,898 | ) | 18,172 | (24,855 | ) | ||||||||||
Net cash provided by operating activities
|
80,273 | 70,232 | 344,297 | 225,395 | ||||||||||||
Investing activities:
|
||||||||||||||||
Purchases of equipment
|
(25,597 | ) | (14,660 | ) | (78,145 | ) | (60,581 | ) | ||||||||
Purchases of investments
|
(71,972 | ) | (87,759 | ) | (306,437 | ) | (345,968 | ) | ||||||||
Sales and maturities of investments
|
84,341 | 76,254 | 298,006 | 302,667 | ||||||||||||
Net cash paid in business combinations
|
– | (81,000 | ) | – | (84,253 | ) | ||||||||||
Proceeds from sale of subsidiary, net of cash surrendered
|
– | – | 9,162 | – | ||||||||||||
(Increase) decrease in deferred contract costs
|
7,189 | (10,065 | ) | (11,610 | ) | (42,830 | ) | |||||||||
(Increase) decrease in restricted investments
|
387 | 4,330 | (2,647 | ) | (4,064 | ) | ||||||||||
Change in other noncurrent assets and liabilities
|
2,862 | (1,365 | ) | (1,913 | ) | (1,898 | ) | |||||||||
Net cash used in investing activities
|
(2,790 | ) | (114,265 | ) | (93,584 | ) | (236,927 | ) | ||||||||
Financing activities:
|
||||||||||||||||
Amount borrowed under term loan
|
– | 48,600 | – | 48,600 | ||||||||||||
Amount borrowed under credit facility
|
– | – | 60,000 | – | ||||||||||||
Repayment of amount borrowed under credit facility
|
– | – | (20,000 | ) | – | |||||||||||
Treasury stock purchases
|
(3,000 | ) | – | (3,000 | ) | (7,000 | ) | |||||||||
Credit facility fees paid
|
– | – | – | (1,125 | ) | |||||||||||
Principal payments on term loan
|
(283 | ) | – | (1,129 | ) | – | ||||||||||
Proceeds from employee stock plans
|
6,121 | 1,707 | 11,692 | 7,347 | ||||||||||||
Excess tax benefits from employee stock compensation
|
(31 | ) | 61 | 3,667 | 1,651 | |||||||||||
Net cash provided by financing activities
|
2,807 | 50,368 | 51,230 | 49,473 | ||||||||||||
Net increase in cash and cash equivalents
|
80,290 | 6,335 | 301,943 | 37,941 | ||||||||||||
Cash and cash equivalents at beginning of period
|
715,480 | 487,492 | 493,827 | 455,886 | ||||||||||||
Cash and cash equivalents at end of period
|
$ | 795,770 | $ | 493,827 | $ | 795,770 | $ | 493,827 |
●
|
Amortization of purchased intangibles relating to customer relationships is reported as amortization within the heading “Depreciation and amortization;”
|
●
|
Amortization of purchased intangibles relating to contract backlog is recorded as a reduction of “Service revenue;” and
|
●
|
Depreciation is recorded within the heading “Cost of service revenue.”
|
Three Months Ended December 31,
|
||||||||||||||||
2012
|
2011
|
|||||||||||||||
Amount
|
% of Total
Revenue
|
Amount
|
% of Total
Revenue
|
|||||||||||||
(Dollar amounts in thousands)
|
||||||||||||||||
Depreciation and amortization of capitalized software
|
$ | 11,677 | 0.7 | % | $ | 8,005 | 0.6 | % | ||||||||
Amortization of intangible assets
|
4,581 | 0.3 | 4,098 | 0.3 | ||||||||||||
Depreciation and amortization reported as such in the consolidated statements of operations
|
16,258 | 1.0 | 12,103 | 0.9 | ||||||||||||
Amortization recorded as reduction of service revenue
|
729 | – | 1,545 | 0.1 | ||||||||||||
Amortization of capitalized software recorded as cost of service revenue
|
3,488 | 0.2 | 8,321 | 0.6 | ||||||||||||
Total
|
$ | 20,475 | 1.2 | % | $ | 21,969 | 1.6 | % |
Year Ended December 31,
|
||||||||||||||||
2012
|
2011
|
|||||||||||||||
Amount
|
% of Total
Revenue
|
Amount
|
% of Total
Revenue
|
|||||||||||||
(Dollar amounts in thousands)
|
||||||||||||||||
Depreciation and amortization of capitalized software
|
$ | 43,201 | 0.7 | % | $ | 30,864 | 0.7 | % | ||||||||
Amortization of intangible assets
|
20,503 | 0.3 | 19,826 | 0.4 | ||||||||||||
Depreciation and amortization reported as such in the consolidated statements of operations
|
63,704 | 1.0 | 50,690 | 1.1 | ||||||||||||
Amortization recorded as reduction of service revenue
|
1,571 | – | 6,822 | 0.1 | ||||||||||||
Amortization of capitalized software recorded as cost of service revenue
|
13,489 | 0.2 | 16,871 | 0.4 | ||||||||||||
Total
|
$ | 78,764 | 1.2 | % | $ | 74,383 | 1.6 | % |
As of December 31,
|
||||||||||||
2012
|
2011
|
2010
|
||||||||||
Total Ending Membership by Health Plan:
|
||||||||||||
California
|
336,000 | 355,000 | 344,000 | |||||||||
Florida
|
73,000 | 69,000 | 61,000 | |||||||||
Michigan
|
220,000 | 222,000 | 227,000 | |||||||||
Missouri (1)
|
– | 79,000 | 81,000 | |||||||||
New Mexico
|
91,000 | 88,000 | 91,000 | |||||||||
Ohio
|
244,000 | 248,000 | 245,000 | |||||||||
Texas
|
282,000 | 155,000 | 94,000 | |||||||||
Utah
|
87,000 | 84,000 | 79,000 | |||||||||
Washington
|
418,000 | 355,000 | 355,000 | |||||||||
Wisconsin
|
46,000 | 42,000 | 36,000 | |||||||||
Total
|
1,797,000 | 1,697,000 | 1,613,000 | |||||||||
Total Ending Membership by State for the Medicare Advantage Plans:
|
||||||||||||
California
|
7,700 | 6,900 | 4,900 | |||||||||
Florida
|
900 | 800 | 500 | |||||||||
Michigan
|
9,700 | 8,200 | 6,300 | |||||||||
New Mexico
|
900 | 800 | 600 | |||||||||
Ohio
|
300 | 200 | – | |||||||||
Texas
|
1,500 | 700 | 700 | |||||||||
Utah
|
8,200 | 8,400 | 8,900 | |||||||||
Washington
|
6,500 | 5,000 | 2,600 | |||||||||
Total
|
35,700 | 31,000 | 24,500 | |||||||||
Total Ending Membership by State for the Aged, Blind or Disabled Population:
|
||||||||||||
California
|
44,700 | 31,500 | 13,900 | |||||||||
Florida
|
10,300 | 10,400 | 10,000 | |||||||||
Michigan
|
41,900 | 37,500 | 31,700 | |||||||||
New Mexico
|
5,700 | 5,600 | 5,700 | |||||||||
Ohio
|
28,200 | 29,100 | 28,200 | |||||||||
Texas
|
95,900 | 63,700 | 19,000 | |||||||||
Utah
|
9,000 | 8,500 | 8,000 | |||||||||
Washington
|
30,000 | 4,800 | 4,000 | |||||||||
Wisconsin
|
1,700 | 1,700 | 1,700 | |||||||||
Total
|
267,400 | 192,800 | 122,200 |
(1)
|
The Company’s contract with the state of Missouri expired without renewal on June 30, 2012.
|
Three Months Ended December 31, 2012
|
||||||||||||||||||||||||
Member
Months (1)
|
Premium Revenue
|
Medical Care Costs
|
MCR
Excluding
Premium
Tax
Expense (5)
|
|||||||||||||||||||||
Total
|
PMPM
|
Total
|
PMPM
|
|||||||||||||||||||||
California
|
1,021 | $ | 179,078 | $ | 175.44 | $ | 159,800 | $ | 156.55 | 89.2 | % | |||||||||||||
Florida
|
218 | 57,892 | 266.06 | 48,965 | 225.04 | 84.6 | ||||||||||||||||||
Michigan
|
656 | 166,453 | 253.54 | 151,230 | 230.35 | 90.9 | ||||||||||||||||||
Missouri (2)
|
– | – | – | – | – | – | ||||||||||||||||||
New Mexico
|
268 | 83,115 | 309.59 | 71,440 | 266.10 | 86.0 | ||||||||||||||||||
Ohio
|
752 | 267,918 | 356.60 | 235,072 | 312.88 | 87.7 | ||||||||||||||||||
Texas
|
856 | 341,244 | 398.69 | 265,391 | 310.07 | 77.8 | ||||||||||||||||||
Utah
|
259 | 72,859 | 281.46 | 61,741 | 238.51 | 84.7 | ||||||||||||||||||
Washington
|
1,248 | 290,246 | 232.56 | 253,335 | 202.99 | 87.3 | ||||||||||||||||||
Wisconsin (3)
|
134 | 18,469 | 138.66 | 13,107 | 98.41 | 71.0 | ||||||||||||||||||
Other (4)
|
– | 2,740 | – | 13,543 | – | – | ||||||||||||||||||
5,412 | $ | 1,480,014 | $ | 273.54 | $ | 1,273,624 | $ | 235.40 | 86.1 | % |
Three Months Ended December 31, 2011
|
||||||||||||||||||||||||
Member
Months (1)
|
Premium Revenue
|
Medical Care Costs
|
MCR
Excluding
Premium
Tax
Expense (5)
|
|||||||||||||||||||||
Total
|
PMPM
|
Total
|
PMPM
|
|||||||||||||||||||||
California
|
1,057 | $ | 153,653 | $ | 145.39 | $ | 133,575 | $ | 126.39 | 86.9 | % | |||||||||||||
Florida
|
200 | 53,377 | 266.19 | 45,486 | 226.84 | 85.2 | ||||||||||||||||||
Michigan
|
658 | 156,641 | 238.12 | 137,827 | 209.52 | 88.0 | ||||||||||||||||||
Missouri (2)
|
237 | 59,596 | 251.32 | 47,697 | 201.14 | 80.0 | ||||||||||||||||||
New Mexico
|
266 | 96,696 | 363.71 | 71,679 | 269.61 | 74.1 | ||||||||||||||||||
Ohio
|
748 | 272,019 | 363.45 | 233,733 | 312.30 | 85.9 | ||||||||||||||||||
Texas
|
462 | 116,407 | 252.19 | 110,667 | 239.76 | 95.1 | ||||||||||||||||||
Utah
|
249 | 72,085 | 289.39 | 56,908 | 228.46 | 78.9 | ||||||||||||||||||
Washington
|
1,067 | 210,559 | 197.30 | 174,744 | 163.74 | 83.0 | ||||||||||||||||||
Wisconsin
|
124 | 18,070 | 145.93 | 16,896 | 136.45 | 93.5 | ||||||||||||||||||
Other (4)
|
– | 1,910 | – | 8,733 | – | – | ||||||||||||||||||
5,068 | $ | 1,211,013 | $ | 238.94 | $ | 1,037,945 | $ | 204.79 | 85.7 | % |
(1)
|
A member month is defined as the aggregate of each month’s ending membership for the period presented.
|
(2)
|
The Company’s contract with the state of Missouri expired without renewal on June 30, 2012. The Missouri health plan’s claims run-out activity subsequent to June 30, 2012, is reported in “Other.”
|
(3)
|
Absent amortization of $1.5 million premium deficiency reserve in the fourth quarter 2012, the Wisconsin health plan’s MCR would have been approximately 79.1%.
|
(4)
|
“Other” medical care costs also include medically related administrative costs at the parent company.
|
(5)
|
The MCR Excluding Premium Tax Expense represents medical costs as a percentage of premium revenue, where premium revenue is reduced by premium tax expense.
|
Year Ended December 31, 2012
|
||||||||||||||||||||||||
Member
Months (1)
|
Premium Revenue
|
Medical Care Costs
|
MCR
Excluding
Premium
Tax
Expense (4)
|
|||||||||||||||||||||
Total
|
PMPM
|
Total
|
PMPM
|
|||||||||||||||||||||
California
|
4,177 | $ | 665,792 | $ | 159.40 | $ | 606,494 | $ | 145.20 | 91.1 | % | |||||||||||||
Florida
|
850 | 228,832 | 269.36 | 195,226 | 229.80 | 85.3 | ||||||||||||||||||
Michigan
|
2,639 | 646,551 | 244.97 | 570,636 | 216.20 | 88.3 | ||||||||||||||||||
Missouri (2)
|
483 | 113,818 | 235.63 | 113,101 | 234.15 | 99.4 | ||||||||||||||||||
New Mexico
|
1,069 | 330,562 | 309.22 | 280,108 | 262.03 | 84.7 | ||||||||||||||||||
Ohio
|
3,065 | 1,095,137 | 357.36 | 970,504 | 316.69 | 88.6 | ||||||||||||||||||
Texas
|
3,245 | 1,233,621 | 380.18 | 1,155,433 | 356.08 | 93.7 | ||||||||||||||||||
Utah
|
1,026 | 298,392 | 290.78 | 245,671 | 239.41 | 82.3 | ||||||||||||||||||
Washington
|
4,600 | 974,712 | 211.91 | 845,733 | 183.87 | 86.8 | ||||||||||||||||||
Wisconsin
|
508 | 70,678 | 139.25 | 67,968 | 133.91 | 96.2 | ||||||||||||||||||
Other (3)
|
– | 9,405 | – | 45,886 | – | – | ||||||||||||||||||
21,662 | $ | 5,667,500 | $ | 261.65 | $ | 5,096,760 | $ | 235.30 | 89.9 | % | ||||||||||||||
Year Ended December 31, 2011
|
||||||||||||||||||||||||
Member
Months (1)
|
Premium Revenue
|
Medical Care Costs
|
MCR
Excluding Premium Tax
Expense (4)
|
|||||||||||||||||||||
Total
|
PMPM
|
Total
|
PMPM
|
|||||||||||||||||||||
California
|
4,190 | $ | 567,677 | $ | 135.48 | $ | 493,419 | $ | 117.75 | 86.9 | % | |||||||||||||
Florida
|
788 | 203,904 | 258.65 | 187,358 | 237.66 | 91.9 | ||||||||||||||||||
Michigan
|
2,660 | 623,394 | 234.35 | 537,779 | 202.16 | 86.3 | ||||||||||||||||||
Missouri (2)
|
959 | 229,584 | 239.38 | 195,832 | 204.19 | 85.3 | ||||||||||||||||||
New Mexico
|
1,074 | 336,447 | 313.29 | 277,338 | 258.25 | 82.4 | ||||||||||||||||||
Ohio
|
2,966 | 912,219 | 307.55 | 766,949 | 258.57 | 84.1 | ||||||||||||||||||
Texas
|
1,616 | 402,178 | 248.99 | 382,390 | 236.74 | 95.1 | ||||||||||||||||||
Utah
|
972 | 287,290 | 295.51 | 224,513 | 230.94 | 78.1 | ||||||||||||||||||
Washington
|
4,171 | 808,458 | 193.85 | 690,513 | 165.57 | 85.4 | ||||||||||||||||||
Wisconsin
|
488 | 69,552 | 142.47 | 64,346 | 131.81 | 92.5 | ||||||||||||||||||
Other (3)
|
– | 8,115 | – | 39,557 | – | – | ||||||||||||||||||
19,884 | $ | 4,448,818 | $ | 223.74 | $ | 3,859,994 | $ | 194.13 | 86.8 | % |
(1)
|
A member month is defined as the aggregate of each month’s ending membership for the period presented.
|
(2)
|
The Company’s contract with the state of Missouri expired without renewal on June 30, 2012. The Missouri health plan’s claims run-out activity subsequent to June 30, 2012, is reported in “Other.”
|
(3)
|
“Other” medical care costs also include medically related administrative costs at the parent company.
|
(4)
|
The MCR Excluding Premium Tax Expense represents medical costs as a percentage of premium revenue, where premium revenue is reduced by premium tax expense.
|
Three Months Ended December 31,
|
||||||||||||||||||||||||
2012
|
2011
|
|||||||||||||||||||||||
Amount
|
PMPM
|
% of
Total
|
Amount
|
PMPM
|
% of
Total
|
|||||||||||||||||||
Fee for service
|
$ | 855,490 | $ | 158.12 | 67.2 | % | $ | 713,879 | $ | 140.85 | 68.8 | % | ||||||||||||
Capitation
|
139,444 | 25.77 | 10.9 | 134,880 | 26.61 | 13.0 | ||||||||||||||||||
Pharmacy
|
229,826 | 42.48 | 18.1 | 149,370 | 29.47 | 14.4 | ||||||||||||||||||
Other
|
48,864 | 9.03 | 3.8 | 39,816 | 7.86 | 3.8 | ||||||||||||||||||
Total
|
$ | 1,273,624 | $ | 235.40 | 100.0 | % | $ | 1,037,945 | $ | 204.79 | 100.0 | % |
Year Ended December 31,
|
||||||||||||||||||||||||
2012
|
2011
|
|||||||||||||||||||||||
Amount
|
PMPM
|
% of
Total
|
Amount
|
PMPM
|
% of
Total
|
|||||||||||||||||||
Fee for service
|
$ | 3,521,960 | $ | 162.60 | 69.1 | % | $ | 2,764,309 | $ | 139.02 | 71.6 | % | ||||||||||||
Capitation
|
557,087 | 25.72 | 10.9 | 518,835 | 26.09 | 13.4 | ||||||||||||||||||
Pharmacy
|
835,830 | 38.59 | 16.4 | 418,007 | 21.02 | 10.8 | ||||||||||||||||||
Other
|
181,883 | 8.39 | 3.6 | 158,843 | 8.00 | 4.2 | ||||||||||||||||||
Total
|
$ | 5,096,760 | $ | 235.30 | 100.0 | % | $ | 3,859,994 | $ | 194.13 | 100.0 | % |
Dec. 31,
2012
|
Sept. 30,
2012
|
Dec. 31,
2011
|
||||||||||
Fee-for-service claims incurred but not paid (IBNP)
|
$ | 377,614 | $ | 414,725 | $ | 301,020 | ||||||
Capitation payable
|
49,066 | 55,314 | 53,532 | |||||||||
Pharmacy
|
38,992 | 42,681 | 26,178 | |||||||||
Other
|
28,858 | 23,743 | 21,746 | |||||||||
$ | 494,530 | $ | 536,463 | $ | 402,476 |
Three Months Ended
December 31,
|
Year Ended
December 31,
|
|||||||||||||||
2012
|
2011
|
2012
|
2011
|
|||||||||||||
(Dollars in thousands, except per-member amounts)
|
||||||||||||||||
Balances at beginning of period
|
$ | 536,463 | $ | 361,055 | $ | 402,476 | $ | 354,356 | ||||||||
Components of medical care costs related to:
|
||||||||||||||||
Current period
|
1,350,043 | 1,069,228 | 5,136,055 | 3,911,803 | ||||||||||||
Prior period
|
(76,419 | ) | (31,283 | ) | (39,295 | ) | (51,809 | ) | ||||||||
Total medical care costs
|
1,273,624 | 1,037,945 | 5,096,760 | 3,859,994 | ||||||||||||
Payments for medical care costs related to:
|
||||||||||||||||
Current period
|
1,725,006 | 708,538 | 5,360,049 | 3,516,994 | ||||||||||||
Prior period
|
(409,449 | ) | 287,986 | (355,343 | ) | 294,880 | ||||||||||
Total paid
|
1,315,557 | 996,524 | 5,004,706 | 3,811,874 | ||||||||||||
Balances at end of period
|
$ | 494,530 | $ | 402,476 | $ | 494,530 | $ | 402,476 | ||||||||
Benefit from prior period as a percentage of:
|
||||||||||||||||
Balance at beginning of period
|
14.2 | % | 8.7 | % | 9.8 | % | 14.6 | % | ||||||||
Premium revenue
|
5.2 | % | 2.6 | % | 0.7 | % | 1.2 | % | ||||||||
Total medical care costs
|
6.0 | % | 3.0 | % | 0.8 | % | 1.3 | % | ||||||||
Claims Data:
|
||||||||||||||||
Days in claims payable, fee for service
|
40 | 40 | 40 | 40 | ||||||||||||
Number of members at end of year
|
1,797,000 | 1,697,000 | 1,797,000 | 1,697,000 | ||||||||||||
Number of claims in inventory at end of year
|
122,700 | 111,100 | 122,700 | 111,100 | ||||||||||||
Billed charges of claims in inventory at end of year
|
$ | 255,200 | $ | 207,600 | $ | 255,200 | $ | 207,600 | ||||||||
Claims in inventory per member at end of year
|
0.07 | 0.07 | 0.07 | 0.07 | ||||||||||||
Billed charges of claims in inventory per member at end of year
|
$ | 142.01 | $ | 122.33 | $ | 142.01 | $ | 122.33 | ||||||||
Number of claims received during the year
|
5,378,400 | 4,342,800 | 20,842,400 | 17,207,500 | ||||||||||||
Billed charges of claims received during the year
|
$ | 5,089,600 | $ | 3,732,500 | $ | 19,429,300 | $ | 14,306,500 |
Total Revenue
|
$ | 7.0B | ||
Medical Care Costs
|
$ | 5.9B | ||
Medical Care Ratio
|
88 | % | ||
Service Costs
|
$ | 170M | ||
G&A Expense
|
$ | 600M | ||
G&A Ratio
|
8.6 | % | ||
Premium Tax Expense
|
$ | 160M | ||
Income Before Tax
|
$ | 128M | ||
Income Tax
|
$ | 54M | ||
Effective Tax Rate
|
42.0 | % | ||
Net Income
|
$ | 74M | ||
Weighted Average Diluted Shares Outstanding
|
47.7 | M | ||
Diluted EPS
|
$ | 1.55 | ||
EBITDA
|
$ | 245M |